A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study. (Record no. 19527494)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01912 a2200589 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515205748.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201011s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1476-5497 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1038/ijo.2010.21 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Aronne, L J |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20101104 |
245 00 - TITLE STATEMENT | |
Title | A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | International journal of obesity (2005) |
Date of publication, distribution, etc. | May 2010 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 919-35 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Amides |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Obesity Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Body Mass Index |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Body Weight |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diet, Reducing |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Metabolic Syndrome |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Obesity |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptor, Cannabinoid, CB1 |
General subdivision | agonists |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Assessment |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Young Adult |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tonstad, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Moreno, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gantz, I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Erondu, N |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Suryawanshi, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Molony, C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sieberts, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nayee, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Meehan, A G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shapiro, D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Heymsfield, S B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kaufman, K D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Amatruda, J M |
773 0# - HOST ITEM ENTRY | |
Title | International journal of obesity (2005) |
Related parts | vol. 34 |
-- | no. 5 |
-- | p. 919-35 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1038/ijo.2010.21">https://doi.org/10.1038/ijo.2010.21</a> |
Public note | Available from publisher's website |
No items available.